Julian Glandorf

Julian Glandorf

Auto-generated profile, based on publicly available information

Julian Glandorf

Institute of Diagnostic and Interventional Radiology Hannover Medical School Hannover Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2020 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
FKFilip Klimeš
Filip Klimeš
AVAndreas Voskrebenzev
Andreas Voskrebenzev
MGMarcel Gutberlet
Marcel Gutberlet
AKAgilo Luitger Kern
Agilo Luitger Kern
LBLea Behrendt
Lea Behrendt
JVJens Vogel-Claussen
Jens Vogel-Claussen
Purpose: To test the feasibility of 3D phase‐resolved functional lung (PREFUL) MRI in healthy volunteers and patients with chronic pulmonary disease, to compare 3D to 2D PREFUL, and to investigate the required temporal resolution to obtain stable 3D PREFUL measurement.Methods: Sixteen participants underwent MRI using 2D and 3D PREFUL. Retrospectively, the spatial resolution of 3D PREFUL (4 × 4 × 4 mm3) was decreased to match the spatial resolution of 2D PREFUL (4 × 4 × 15 mm3), abbreviated as 3Dlowres. In addition to regional ventilation (RVent), flow‐volume loops were computed and rated by a cross‐correlation (CC). Ventilation defect percentage (VDP) maps were obtained. RVent, CC, VDPRVent, and VDPCC were compared for systematic differences between 2D, 3Dlowres, and 3D PREFUL. Dividing the 3D PREFUL data into 4‐ (≈ 20 phases), 8‐ (≈ 40 phases), and 12‐min (≈ 60 phases) acquisition pieces, the ventilation parameter maps, including the heterogeneity of ventilation time to peak, were tested regarding the required temporal resolution.Results: RVent, CC, VDPRVent, and VDPCC presented significant correlations between 2D and 3D PREFUL (r = 0.64‐0.94). CC and VDPCC of 2D and 3Dlowres PREFUL were significantly different (P < .0113). Comparing 3Dlowres and 3D PREFUL, all parameters were found to be statistically different (P < .0045).Conclusion: 3D PREFUL MRI depicts the whole lung volume and breathing cycle with superior image resolution and with likely more precision compared to 2D PREFUL. Furthermore, 3D PREFUL is more sensitive to detect regions of hypoventilation and ventilation heterogeneity compared to 3Dlowres PREFUL, which is important for early detection and improved monitoring of patients with chronic lung disease.

1 April 2024 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
MDMartha Dohna
Martha Dohna
AVAndreas Voskrebenzev
Andreas Voskrebenzev
FKFilip Klimeš
Filip Klimeš
TKTill F. Kaireit
Till F. Kaireit
JGJulian Glandorf
Julian Glandorf
JVJens Vogel-Claussen
Jens Vogel-Claussen
Purpose To assess the feasibility of monitoring the effects of elexacaftor-tezacaftor-ivacaftor (ETI) therapy on lung ventilation and perfusion in people with cystic fibrosis (CF), using phase-resolved functional lung (PREFUL) MRI. Materials and Methods This secondary analysis of a multicenter prospective study was carried out between August 2020 and March 2021 and included participants 12 years or older with CF who underwent PREFUL MRI, spirometry, sweat chloride test, and lung clearance index assessment before and 8-16 weeks after ETI therapy. For PREFUL-derived ventilation and perfusion parameter extraction, two-dimensional coronal dynamic gradient-echo MR images were evaluated with an automated quantitative pipeline. T1- and T2-weighted MR images and PREFUL perfusion maps were visually assessed for semiquantitative Eichinger scores. Wilcoxon signed rank test compared clinical parameters and PREFUL values before and after ETI therapy. Correlation of parameters was calculated as Spearman ρ correlation coefficient. Results Twenty-three participants (median age, 18 years [IQR: 14-24.5 years]; 13 female) were included. Quantitative PREFUL parameters, Eichinger score, and clinical parameters (lung clearance index = 21) showed significant improvement after ETI therapy. Ventilation defect percentage of regional ventilation decreased from 18% (IQR: 14%-25%) to 9% (IQR: 6%-17%) (P = .003) and perfusion defect percentage from 26% (IQR: 18%-36%) to 19% (IQR: 13%-24%) (P = .002). Areas of matching normal (healthy) ventilation and perfusion increased from 52% (IQR: 47%-68%) to 73% (IQR: 61%-83%). Visually assessed perfusion scores did not correlate with PREFUL perfusion (P = .11) nor with ventilation-perfusion match values (P = .38). Conclusion The study demonstrates the feasibility of PREFUL MRI for semiautomated quantitative assessment of perfusion and ventilation changes in response to ETI therapy in people with CF. Keywords: Pediatrics, MR-Functional Imaging, Pulmonary, Lung, Comparative Studies, Cystic Fibrosis, Elexacaftor-Tezacaftor-Ivacaftor Therapy, Fourier Decomposition, PREFUL, Free-Breathing Proton MRI, Pulmonary MRI, Perfusion, Functional MRI, CFTR, Modulator Therapy, Kaftrio Clinical trial registration no. NCT04732910 Supplemental material is available for this article. © RSNA, 2024.

1 May 2023 in Radiology
Verified
Journal Article
Closed access
JVJens Vogel-Claussen
Jens Vogel-Claussen
TKTill F. Kaireit
Till F. Kaireit
AVAndreas Voskrebenzev
Andreas Voskrebenzev
FKFilip Klimeš
Filip Klimeš
JGJulian Glandorf
Julian Glandorf
JGJens Gottlieb
Jens Gottlieb
Background Chronic lung allograft dysfunction (CLAD), the physiologic correlate of chronic rejection, remains a major barrier to long-term survival following lung transplant. Biomarkers for early prediction of future transplant loss or death due to CLAD might open a window of opportunity for early diagnosis and treatment of CLAD. Purpose To evaluate the prognostic use of phase-resolved functional lung (PREFUL) MRI in predicting CLAD-related transplant loss or death. Materials and Methods In this prospective, longitudinal, single-center study, PREFUL MRI-derived ventilation and parenchymal lung perfusion parameters of bilateral lung transplant recipients without clinically suspected CLAD were assessed 6-12 months (baseline) and 2.5 years (follow-up) after transplant. MRI scans were acquired between August 2013 and December 2018. Regional flow volume loop (RFVL)-based ventilated volume (VV) and perfused volume were calculated using thresholds and spatially combined as ventilation-perfusion (V/Q) matching. Spirometry data were obtained on the same day. Exploratory models were calculated using receiver operating characteristic analysis, and subsequent survival analyses (Kaplan-Meier, hazard ratios [HRs]) of CLAD-related graft loss were performed to compare clinical and MRI parameters as clinical end points. Results At baseline MRI examination, 132 clinically stable patients of 141 patients (median age, 53 years [IQR, 43-59 years]; 78 men) were included (nine were excluded for deaths not associated with CLAD), 24 of which had CLAD-related graft loss (death or retransplant) within the observational period of 5.6 years. PREFUL MRI-derived RFVL VV was a predictor of poorer survival (cutoff, 92.3%; log-rank P = .02; HR for graft loss, 2.5 [95% CI: 1.1, 5.7]; P = .02), while perfused volume (P = .12) and spirometry (P = .33) were not predictive of differences in survival. In the evaluation of percentage change at follow-up MRI (92 stable patients vs 11 with CLAD-related graft loss), mean RFVL (cutoff, 97.1%; log-rank P < .001; HR, 7.7 [95% CI: 2.3, 25.3]), V/Q defect (cutoff, 498%; log-rank P = .003; HR, 6.6 [95% CI: 1.7, 25.0]), and forced expiratory volume in the first second of expiration (cutoff, 60.8%; log-rank P < .001; HR, 7.9 [95% CI: 2.3, 27.4]; P = .001) were predictive of poorer survival within 2.7 years (IQR, 2.2-3.5 years) after follow-up MRI. Conclusion Phase-resolved functional lung MRI ventilation-perfusion matching parameters were predictive of future chronic lung allograft dysfunction-related death or transplant loss in a large prospective cohort who had undergone lung transplant. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Fain and Schiebler in this issue.

9 February 2021 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
FKFilip Klimeš
Filip Klimeš
AVAndreas Voskrebenzev
Andreas Voskrebenzev
MGMarcel Gutberlet
Marcel Gutberlet
AOArnd J. Obert
Arnd J. Obert
GPGesa H. Pöhler
Gesa H. Pöhler
JVJens Vogel-Claussen
Jens Vogel-Claussen
Background: A previous study has demonstrated the feasibility of 3D phase‐resolved functional lung (PREFUL) MRI in healthy volunteers and patients with chronic pulmonary disease. Before clinical use, the repeatability of the ventilation parameters derived from 3D PREFUL MRI must be determined.Purpose: To evaluate repeatability of 3D PREFUL and to compare with pulmonary functional lung testing (PFT).Study Type: Prospective.Population: Fifty‐three healthy subjects and 13 patients with chronic obstructive pulmonary disease (COPD).Field Strength/Sequence: A prototype 3D stack‐of‐stars spoiled‐gradient‐echo sequence at 1.5 T.Assessment: Study participants underwent repeated MRI examination (median time interval between scans COPD/healthy subjects [interquartile range]: 7/0 days [6–8/0–0 days]) and one PFT carried out at the time of the baseline MRI. For 3D PREFUL, regional ventilation (RVent) and flow‐volume loops were computed and rated by cross‐correlation (CC). Also, ventilation time‐to‐peak (VTTP) was computed. Ventilation defect percentage (VDP) maps were obtained for RVent and CC.Statistical Tests: Repeatability of 3D PREFUL parameters was evaluated using Bland–Altman analysis, coefficient of variation (COV) and intraclass correlation coefficient (ICC). The relation between 3D PREFUL and PFT measures (forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) was assessed using the Pearson correlation coefficient (r).Results: In healthy subjects and COPD patients, no significant bias (all P range: 0.09–0.77) and a moderate to good repeatability of RVent, VTTP, and VDPRVent were found (COV range: 0.1%–18.2%, ICC range: 0.51–0.88). For CC and VDPCC moderate repeatability was found (COV range: 0.6%–43.6%, ICC: 0.38–0.60). CC, VDPRVent, and VDPCC showed a good correlation with FEV1 (all |r| > 0.58, all P < 0.05) and FEV1/FVC ratio (all |r| > 0.62, all P < 0.05).Data Conclusion: 3D PREFUL provided a good repeatability of RVent, VTTP, and VDPRVent and moderate repeatability of CC and VDPCC in healthy volunteers and COPD patients, and correlated well with FEV1 and FEV1/FVC.Level of Evidence: 2Technical Efficacy Stage: 2

30 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JGJulian Glandorf
Julian Glandorf
FKFilip Klimeš
Filip Klimeš
AVAndreas Voskrebenzev
Andreas Voskrebenzev
MGMarcel Gutberlet
Marcel Gutberlet
LBLea Behrendt
Lea Behrendt
JVJens Vogel-Claussen
Jens Vogel-Claussen
Purpose: The purpose of this study is to evaluate the influence of different field strengths on perfusion and ventilation parameters, SNR and CNR derived by PREFUL MRI using predefined sequence parameters. Methods: Data sets of free breathing 2d FLASH lung MRI were acquired from 15 healthy subjects at 1.5T and 3T (Magnetom Avanto and Skyra, Siemens Healthcare, Erlangen, Germany) with a maximum period of 3 days in between. The processed functional parameters regional ventilation (RVent), perfusion (Q), quantified perfusion (QQuant), perfusion defect percentage (QDP), ventilation defect percentage (VDP) and ventilation-perfusion match (VQM) were compared for systematic differences. Signal- and contrast-to-noise ratio (SNR and CNR) of both acquisitions were analyzed. Results: RVent, Q, VDP, SNR and CNR presented no significant differences between 1.5T and 3T. QQuant (1.5T vs. 3T, P = 0.04), and QDP (1.5T vs. 3T, P≤0.01) decreased significantly at 3T. Consequently, VQM increased significantly (1.5T vs. 3T, P≤0.01). Skewness and kurtosis of the Q-values increased significantly at 3T (P≤0.01). The mean Sørensen-Dice coefficients between both series were 0.91 for QDP and 0.94 for VDP. The Bland-Altman analysis of both series showed mean differences of 4.29% for QDP, 1.23% for VDP and -5.15% for VQM. Using the above-mentioned parameters for three-day repeatability at two different scanners and field strengths, the retrospective power calculation showed, that a sample size of 15 can detect differences of 3.7% for QDP, of 2.9% for VDP and differences of 2.6% for VQM. Conclusion: Significant differences in QDP may be related to field inhomogeneities, which is expressed by increasing skewness and kurtosis at 3T. QQuant reveals only poor reproducibility between 1.5T and 3T. RVent, Q, VDP, SNR and CNR were not altered significantly at the used sequence parameters. Healthy participants with minimal defects present high spatial agreement of QDP and VDP.

9 April 2021 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
JGJulian Glandorf
Julian Glandorf
FKFilip Klimeš
Filip Klimeš
LBLea Behrendt
Lea Behrendt
AVAndreas Voskrebenzev
Andreas Voskrebenzev
TKTill F. Kaireit
Till F. Kaireit
JVJens Vogel-Claussen
Jens Vogel-Claussen
Purpose: Contrast‐free lung MRI based on Fourier decomposition is an attractive method to monitor various lung diseases. However, the accuracy of the current perfusion quantification is limited. In this study, a new approach for perfusion quantification based on voxel‐wise proton density and median signal decay toward the steady state for Fourier decomposition‐based techniques is proposed called QQuantified (QQuant).Methods: Twenty patients with chronic obstructive pulmonary disease and 18 patients with chronic thromboembolic pulmonary hypertension received phase‐resolved functional lung‐MRI (PREFUL) and dynamic contrast‐enhanced (DCE)‐MRI. Nine healthy participants received phase‐resolved functional lung‐MRI only. Median values of QQuant were compared to a Fourier decomposition perfusion quantification presented by Kjørstad et al (QKjørstad) and validated toward pulmonary blood flow derived by DCE‐MRI (PBFDCE). Blood fraction maps determined by the new approach were calculated. Regional and global correlation coefficients were calculated, and Bland‐Altman plots were created. Histogram analyses of all cohorts were created.Results: The introduced parameter QQuant showed only 2 mL/min/100 mL mean deviation to PBFDCE in the patient cohort and showed less bias than QKjørstad. Significant increases of regional correlation with PBFDCE were achieved (r = 0.3 vs. r = 0.2, P < .01*). The trend of global correlation toward PBFDCE is not uniform, showing higher values for QKjørstad in the chronic obstructive pulmonary disease cohort than for QQuant and vice versa in the chronic thromboembolic pulmonary hypertension cohort. In contrast to QKjørstad, QQuant perfusion maps indicate a physiologic dorsoventral gradient in supine position similar to PBFDCE with similar value distribution in the histograms.Conclusion: We proposed a new approach for perfusion quantification of phase‐resolved functional lung measurements. The developed parameter QQuant reveals a higher accuracy compared to QKjørstad.